Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion.
Toller W, Heringlake M, Guarracino F, Algotsson L, Alvarez J, Argyriadou H, Ben-Gal T, Černý V, Cholley B, Eremenko A, Guerrero-Orriach JL, Järvelä K, Karanovic N, Kivikko M, Lahtinen P, Lomivorotov V, Mehta RH, Mušič Š, Pollesello P, Rex S, Riha H, Rudiger A, Salmenperä M, Szudi L, Tritapepe L, Wyncoll D, Öwall A. Toller W, et al. Among authors: salmenpera m. Int J Cardiol. 2015 Apr 1;184:323-336. doi: 10.1016/j.ijcard.2015.02.022. Epub 2015 Feb 24. Int J Cardiol. 2015. PMID: 25734940 Free article. Review.
Perioperative use of levosimendan: best practice in operative settings.
Toller W, Algotsson L, Guarracino F, Hörmann C, Knotzer J, Lehmann A, Rajek A, Salmenperä M, Schirmer U, Tritapepe L, Weis F, Landoni G. Toller W, et al. Among authors: salmenpera m. J Cardiothorac Vasc Anesth. 2013 Apr;27(2):361-6. doi: 10.1053/j.jvca.2012.04.007. Epub 2012 May 30. J Cardiothorac Vasc Anesth. 2013. PMID: 22658687 Review. No abstract available.
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
Papp Z, Édes I, Fruhwald S, De Hert SG, Salmenperä M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikström BG, Jörgensen K, Filippatos G, Parissis JT, González MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Papp Z, et al. Among authors: salmenpera m. Int J Cardiol. 2012 Aug 23;159(2):82-7. doi: 10.1016/j.ijcard.2011.07.022. Epub 2011 Jul 23. Int J Cardiol. 2012. PMID: 21784540 Review.
Renal effects of levosimendan: a consensus report.
Yilmaz MB, Grossini E, Silva Cardoso JC, Édes I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, Morelli A, le Noble J, Oldner A, Oulego Erroz I, Parissis JT, Parkhomenko A, Poelzl G, Rehberg S, Ricksten SE, Rodríguez Fernández LM, Salmenperä M, Singer M, Treskatsch S, Vrtovec B, Wikström G. Yilmaz MB, et al. Among authors: salmenpera m. Cardiovasc Drugs Ther. 2013 Dec;27(6):581-90. doi: 10.1007/s10557-013-6485-6. Cardiovasc Drugs Ther. 2013. PMID: 23929366 Free PMC article. Review.
Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, Kuitunen AH, Kuttila KT, Peräkylä TK, Sarapohja T, Suojaranta-Ylinen RT, Valtonen M, Salmenperä MT. Eriksson HI, et al. Among authors: salmenpera mt. Ann Thorac Surg. 2009 Feb;87(2):448-54. doi: 10.1016/j.athoracsur.2008.10.029. Ann Thorac Surg. 2009. PMID: 19161758 Clinical Trial.
Levosimendan reversing low output syndrome after heart transplantation.
Petäjä LM, Sipponen JT, Hämmäinen PJ, Eriksson HI, Salmenperä MT, Suojaranta-Ylinen RT. Petäjä LM, et al. Among authors: salmenpera mt. Ann Thorac Surg. 2006 Oct;82(4):1529-31. doi: 10.1016/j.athoracsur.2006.02.026. Ann Thorac Surg. 2006. PMID: 16996977
127 results